Biocon expands Yesintek access to nine markets
Biocon Limited has secured market entry for Yesintek in nine additional countries under a licensing agreement with Janssen Sciences Ireland. The proposed Stelara biosimilar targets autoimmune diseases in a market where the reference drug g…
























